Review
Leptospirosis: a zoonotic disease of global importance

https://doi.org/10.1016/S1473-3099(03)00830-2Get rights and content

Summary

In the past decade, leptospirosis has emerged as a globally important infectious disease. It occurs in urban environments of industrialised and developing countries, as well as in rural regions worldwide. Mortality remains significant, related both to delays in diagnosis due to lack of infrastructure and adequate clinical suspicion, and to other poorly understood reasons that may include inherent pathogenicity of some leptospiral strains or genetically determined host immunopathological responses. Pulmonary haemorrhage is recognised increasingly as a major, often lethal, manifestation of leptospirosis, the pathogenesis of which remains unclear. The completion of the genome sequence of Leptospira interrogans serovar lai, and other continuing leptospiral genome sequencing projects, promise to guide future work on the disease. Mainstays of treatment are still tetracyclines and β—lactam/cephalosporins. No vaccine is available. Prevention is largely dependent on sanitation measures that may be difficult to implement, especially in developing countries.

Section snippets

Microbiology and taxonomy

Leptospires are spirochetes (figure 1), a group of bacteria that diverged early in bacterial evolution.10 The family leptospiraceae includes two genera, Leptospira and Leptonema. Typically, leptospires were classified according to antigenic determinants.11, 12 More recently, a molecular classification has been described that divides the Leptospira genus into several species on the basis of DNA relatedness.13, 14, 15, 16 The reclassification of leptospires using genetic determinants provides

Microbiology

The leptospiral genome consists of two circular chromosomes17 and its entire sequence was recently established.18 The genome is large compared with the genomes of other spirochetes such as Treponema spp19 and Borrelia spp,20 which indicates the ability of Leptospira spp to live within diverse environments: animal hosts and freely in the environment. Little is known about genetic exchange among the Leptospira, although lateral transfer has been suggested.21 Tools for genetic manipulation of

Taxonomy

The species classification of the genus Leptospira is based on DNA relatedness (table 1).13, 14, 15, 16 The genus is divided into 17 species, defined as being at least 70% DNA—related and whose related DNA sequences contain at most 5% unpaired bases (divergence).15 This classification coexists with the older serological classification in which antisera are used to establish antigenic relatedness between isolates.11 Leptospiral strains are still commonly referred to by serovar (Table 1, Table 2

Epidemiology

Leptospirosis has a worldwide distribution. The incidence of human infection is higher in the tropics than in temperate regions but transmission occurs in both industrialised and developing countries. Incidence rates are underestimated due to lack of awareness of the disease and relatively inaccessible and insufficiently rapid diagnostics. Symptom—less or subclinical infection is common in endemic regions.34,35 We have seen that a surprisingly high proportion (20–30%) of patients presenting

Pathogenesis

Host infection by pathogenic Leptospira produces a diverse array of clinical manifestations ranging from subclinical infection to undifferentiated febrile illness to jaundice, renal failure, and potentially lethal pulmonary haemorrhage. Our understanding of mechanisms of leptospirosis pathogenesis is limited. Answers to the most basic questions, such as whether the outcome of infection (mild or severe disease) is due to direct pathogen effects or genetically determined host immune responses,

Clinical features

Leptospirosis has protean manifestations, and mimics the clinical presentations of many other diseases.32, 96 Consequently, mechanisms of the clinical manifestations of leptospirosis remain obscure. Typical descriptions97 include a biphasic illness (anicteric form, figure 10) and fulminant disease (icterohaemorrhagic form, figure 11).9 In the biphasic illness the initial acute or septicaemic phase is characterised by bacteraemia that typically lasts about 1 week. Most of the recognised cases

General laboratory tests

Diagnosis of leptospirosis depends on simple diagnostic tests, which are often not done because of a low index of clinical suspicion. Laboratory diagnosis of leptospirosis can be made either by showing the organism or by serological tests that detect leptospiral antibodies.122 Several non—specific findings may include increased ESR, mild increases in transaminases, alkaline phosphatase, and bilirubin; abnormal urinanalysis showing proteinuria, pyuria, and microscopic haematuria. CSF protein may

Treatment

There remains some controversy about whether antimicrobial treatment of severe leptospirosis should even be initiated since most cases of acute leptospirosis resolve spontaneously.140 However, most experts would not withhold antimicrobial treatment when clinical findings and epidemiological exposure history suggest leptospirosis.140 In the case series reported from Hawaii from 1974–1998, no significant difference was seen between use and non—use of antibiotics and duration of illness.100 In a

Chemoprophylaxis

In a now classic study, a clinical trial comparing doxycycline (200 mg/week) with placebo was done in Panama in 1982 involving 940 US soldiers deployed for jungle training98 22 cases of leptospirosis occurred in the placebo group (attack rate of 4·2%), which was significantly different from the single case in the doxycycline group (attack rate of 0·2%, p<0·001). A randomised clinical trial done on the North Andaman islands of India examined doxycycline prophylaxis against leptospirosis in

Vaccine development

Vaccines to prevent human leptospirosis are available in some countries and large—scale clinical trials have been reported from Cuba,149, 150 Russia,151 and China152 in non—English language journals. In Cuba, there was not a single reported side—effect in more than 100 000 people vaccinated and protection was reported to be 100%.149, 150 Only a few patients developed MAT antibodies to the serovars in the preparation,149, 150 so that in—vitro tests did not correlate with protective immunity.

Search strategy and selection criteria

We identified relevant English language publications from 1966 onwards through Pubmed searches. Keywords used were “leptospirosis” and “leptospira”. To look for reports of human vaccine clinical trials in all languages we used keywords “vaccine”, “leptospirosis”, and “clinical trials”. We also examined reference lists of major reviews, a reference database compiled by Solomon Faine, and the compendium of references by E Ryu, Chronological references of zoonoses: leptospires and

References (158)

  • AE Parma et al.

    C3 fixed in vivo to cornea from horses inoculated with Leptospira interrogans.

    Vet Immunol Immunopathol

    (1992)
  • C Sonrier et al.

    Evidence of crossprotection within Leptospira interrogans in an experimental model

    Vaccine

    (2000)
  • J Truccolo et al.

    Following the course of human leptospirosis: evidence of a critical threshold for the vital prognosis using a quantitative PCR assay

    FEMS Microbiol Lett

    (2001)
  • MM Pereira et al.

    Morphological characterisation of lung and kidney lesions in C3H/HeJ mice infected with Leptospira interrogans serovar icterohaemorrhagiae: defect of CD4+ and CD8+ T-cells are prognosticators of the disease progression

    Exp Toxicol Pathol

    (1998)
  • JM Vinetz

    Leptospirosis

    Curr Opin Infect Dis

    (2001)
  • RT Trevejo et al.

    Epidemic leptospirosis associated with pulmonary haemorrhage—Nicaragua, 1995

    J Infect Dis

    (1998)
  • KM O'Neil et al.

    Pulmonary manifestations of leptospirosis

    Rev Infect Dis

    (1991)
  • LG Heron et al.

    Leptospirosis presenting as a haemorrhagic fever in a traveller from Africa

    Med J Aust

    (1997)
  • J-J Monzuez et al.

    Leptospirosis presenting as haemorrhagic fever in visitor to Africa

    Lancet

    (1997)
  • J Morgan et al.

    Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998

    Clin Infect Dis

    (2002)
  • DA Haake et al.

    Leptospirosis, water sports, and chemoprophylaxis

    Clin Infect Dis

    (2002)
  • DM Sasaki et al.

    Active surveillance and risk factors for leptospirosis in Hawaii

    Am J Trop Med Hyg

    (1993)
  • JM Vinetz et al.

    Sporadic urban leptospirosis

    Ann Intern Med

    (1996)
  • BJ Paster et al.

    Phylogenetic analysis of the spirochetes

    J Bacteriol

    (1991)
  • WJ Terpstra

    Typing leptospira from the perspective of a reference laboratory

    Acta Leiden

    (1992)
  • PH Yasuda et al.

    Deoxyribonucleic acid relatedness between serogroups and serovars in the family Leptospiraceae with proposals for seven new Leptospira species

    Int J Syst Bacteriol

    (1987)
  • P Ramadass et al.

    Genetic characterization of pathogenic Leptospira species by DNA hybridization

    Int J Syst Bacteriol

    (1992)
  • DJ Brenner et al.

    Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp nov and four new Leptospira genomospecies

    Int J Syst Bacteriol

    (1999)
  • P Perolat et al.

    Leptospira fainei sp nov, isolated from pigs in Australia

    Int J Syst Bacteriol

    (1998)
  • C Boursaux-Eude et al.

    Leptospira genomics

    Electrophoresis

    (1998)
  • SX Ren et al.

    Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing

    Nature

    (2003)
  • CM Fraser et al.

    Complete genome sequence of Treponema pallidum, the syphilis spirochete

    Science

    (1998)
  • CM Fraser et al.

    Genomic sequence of a Lyme disease spirochaete, Borrelia burgdorferi.

    Nature

    (1997)
  • I Saint Girons et al.

    The LE1 bacteriophage replicates as a plasmid within Leptospira biflexa: construction of an L biflexa-Escherichia coli shuttle vecto

    J Bacteriol

    (2000)
  • DA Haake

    Spirochaetal lipoproteins and pathogenesis

    Microbiology

    (2000)
  • K Hovind-Hougen

    Determination by means of electron microscopy of morphological criteria of value for classification of some spirochetes, in particular treponemes

    Acta Pathol Microbiol Scand

    (1976)
  • NW Charon et al.

    Genetics of motility and chemotaxis of a fascinating group of bacteria: The spirochetes

    Annu Rev Genet

    (2002)
  • WA Ellis et al.

    Bovine leptospirosis: a serological and clinical study

    Vet Rec

    (1976)
  • S Faine et al.

    Leptospira and leptospirosis

    (1999)
  • HC Ellinghausen et al.

    Nutrition of Leptospira pomona and growth of 13 other serotypes: fractionation of oleic albumin complex and a medium of bovine albumin and polysorbate 80

    Am J Vet Res

    (1965)
  • HC Ellinghausen et al.

    Nutrition of Leptospira pomona and growth of 13 other serotypes: a serum-free medium employing oleic albumin complex

    Am J Vet Res

    (1965)
  • RC Johnson et al.

    Metabolism of leptospires II. The action of 8-azaguanine

    Can J Microbiol

    (1967)
  • PN Levett

    Leptospirosis

    Clin Microbiol Rev

    (2001)
  • E Kmety et al.

    Classification of the species Leptospira interrogans and the history of its serovars

    A history of the publication of the serovars of leptospires, and a catalogue of their relationships

    (1993)
  • P Bovet et al.

    Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean)

    Int J Epidemiol

    (1999)
  • DA Ashford et al.

    Asymptomatic infection and risk factors for leptospirosis in Nicaragua

    Am J Trop Med Hyg

    (2000)
  • FC Leonard et al.

    K OF. Duration of urinary excretion of leptospires by cattle naturally or experimentally infected with Leptospira interrogans serovar hardjo.

    Vet Rec

    (1992)
  • AB Thiermann

    The Norway rat as a selective chronic carrier of Leptospira icterohaemorrhagiae

    J Wildl Dis

    (1981)
  • MA Matthias et al.

    Leptospiral carriage by mice and mongooses on the island of Barbados

    West Indian Med J

    (2002)
  • P Tomich

    Studies of leptospirosis in natural host populations I. Small mammals of Waipio Valley, island of Hawaii

    Pacific Science

    (1979)
  • Cited by (1808)

    • Enhancing leptospirosis control with nanosensing technology: A critical analysis

      2024, Comparative Immunology, Microbiology and Infectious Diseases
    View all citing articles on Scopus
    View full text